Experience With Anti-PD-1 Antibody, Camrelizumab, Monotherapy for Biliary Tract Cancer Patients and Literature Review

Tian Shen,Shanhua Zheng,Lei Geng,Zhengtao Liu,Jun Xu,Bingyi Lin,Junjie Qian,Shusen Zheng

Experience With Anti-PD-1 Antibody, Camrelizumab, Monotherapy for Biliary Tract Cancer Patients and Literature Review

2020

Tian Shen
Shanhua Zheng
Lei Geng
Zhengtao Liu
Jun Xu
Bingyi Lin
Junjie Qian
Shusen Zheng

Background:Novel immunotherapy is one of the options for advanced biliary tract cancer (BTC) patients who are traditionally intolerant to chemotherapy. However, clinical evidence for single immunot...

Keywords:

Immunotherapy
Gastroenterology
clinical evidence
anti pd 1
Internal medicine
Chemotherapy
biliary tract cancer
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations